Free Trial

LianBio (LIAN) SEC Filings & 10K Form

LianBio logo
$0.29
0.00 (0.00%)
(As of 11/4/2024 ET)

Recent LianBio SEC Filings

DateFilerForm TypeView
04/11/2024
3:10 PM
Gu Ehong (Reporting)
LianBio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
7:00 AM
LianBio (Filer)
Form 15-12G
03/12/2024
11:15 PM
LianBio (Filer)
Form EFFECT
03/12/2024
7:30 AM
Citibank,N.A./ADR (Filed by)
LianBio (Subject)
Form F-6 POS
03/12/2024
6:56 AM
LianBio (Filer)
Form POS AM
03/12/2024
7:00 AM
LianBio (Filer)
Form S-8 POS
03/12/2024
7:01 AM
LianBio (Filer)
Form S-8 POS
03/12/2024
7:02 AM
LianBio (Filer)
Form S-8 POS
03/11/2024
6:51 AM
LianBio (Filer)
Form 25
Notification of the removal from listing and registration of matured, redeemed or retired securities  
02/29/2024
6:45 PM
LianBio (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13D/A
02/20/2024
4:23 PM
LianBio (Issuer)
Stone Adam Leo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
4:25 PM
EDELMAN JOSEPH (Reporting)
LianBio (Issuer)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2024
4:27 PM
LianBio (Issuer)
Poukalov Konstantin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
6:04 AM
LianBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2024
5:13 AM
LianBio (Subject)
Wang Yizhe (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/29/2023
6:56 AM
LianBio (Subject)
Wang Yizhe (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/26/2023
3:10 PM
Gu Ehong (Reporting)
LianBio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/20/2023
7:05 AM
LianBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2023
3:23 PM
LianBio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/30/2023
4:08 PM
LianBio (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
Form SC 13D
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:LIAN) was last updated on 11/5/2024 by MarketBeat.com Staff
From Our Partners